Egetis Therapeutics
Egetis Therapeutics: A short-cut to the market (Redeye)
2022-01-18 12:17
Redeye comments on the revised regulatory strategy for marketing authorization for Emcitate, announced by Egetis this morning.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se